Simon G, Altman S
Clin Exp Hypertens A. 1984;6(12):2219-33. doi: 10.3109/10641968409052204.
Compared to values obtained in healthy normotensive control subjects, the serum activity of the lysosomal enzymes N-acetyl-beta-D-glucosaminidase (NAG) and beta-glucuronidase, was found to be elevated in patients with mild or borderline hypertension. The serum activity of the cytosolic enzyme lactate dehydrogenase was the same in the two groups. Serum NAG activity in hypertension was inversely correlated with glomerular filtration rate and renal plasma flow. Because of the greater variability of beta-glucuronidase activity, there were no such correlations between the serum levels of this enzyme and the measurements of renal function.
与健康血压正常的对照受试者所获得的值相比,发现轻度或临界高血压患者溶酶体酶N - 乙酰 - β - D - 氨基葡萄糖苷酶(NAG)和β - 葡萄糖醛酸酶的血清活性升高。两组中细胞溶质酶乳酸脱氢酶的血清活性相同。高血压患者的血清NAG活性与肾小球滤过率和肾血浆流量呈负相关。由于β - 葡萄糖醛酸酶活性的变异性较大,该酶的血清水平与肾功能测量值之间不存在此类相关性。